TNF and metabolic dysfunction-associated steatotic liver disease: The present study addresses this critical knowledge gap by evaluating serum levels of three key inflammatory markers (IL-6, TNF-α, and hsCRP) in a well-characterized cohort of patients with MASLD and systematically analyzing their correlations with: (1) disease severity assessed through five validated non-invasive indices (APRI, FIB-4, NAFLD fibrosis score, FAST score, and transient elastography with controlled attenuation parameter), and (2) key metabolic parameters, including anthropometric indices, glycemic control, and comprehensive lipid profiling.